Compare2 funds · 1 pair
Picked · 2YTD
BBCvsIXJVersus · 5Y · 0.0% held in common2–4measures won
Close to theseFee · YTD
Best of the twoNov 4
  • Lowest cost$ a year on $10kIXJ 0.38%
  • Most incometrailing 12-month yieldBBC 1.50%
  • Best 5 yearsper yearIXJ +7.6%
  • Smallest drop · 1Yworst fall in the past yearIXJ −10.8%
Measures won2–4IXJ wins · of 6 · 5Y
$10,000 · 5Y$14,393IXJ · BBC $10,290
Lowest cost0.38%IXJ · $38 on $10k
Most income1.50%BBC · $150 on $10k
Smallest drop−10.8%IXJ · worst fall in 1Y
Held in common0.0%BBC and IXJ

BBC vs IXJ

5Y
BBC
IXJ
Virtus Biotech Clinical Trials ETF · $33MiShares Global Healthcare ETF · $4.6B
+37.4%3 years · per year$25,933 · $15,304+15.2%
+0.6%5 years · per year$10,290 · $14,393+7.6%
0.65%Expense ratio$65 · $38 on $10k · lower wins0.38%
1.50%12-mo yield$150 · $125 on $10k1.25%
−30.2%Worst dropSmaller wins−10.8%
37.6%VolatilityLower wins16.1%
2–4IXJ wins
$10,000 · 5 yearsOne scale
$10k startIXJ $14.4kBBC $10.3kOct 2021Nov 2026
Shared top holdingsBBC · IXJ

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 4, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BIXJiShares Global Healthcare ETFReadDesk0.38%1.25%+3.2%+19.7%+28.6%+15.2%+7.6%−10.8%$4.6B
2ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.50%+1.9%+13.1%+43.3%+37.4%+0.6%−30.2%$33M
End-of-day Nov 4, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs IXJ

5Y
Virtus Biotech Clinical Trials
$10,290
iShares Global Healthcare
$14,393
$5k$10kNov 2021Nov 2026$10,290$14,393$5k$10kNov 2021Nov 2026$10,290$14,393
MeasureBBCIXJ
Fee0.65%0.38%
Cost on $10k a year$65$38
Yield1.50%1.25%
5 years, per year+0.6%+7.6%
3 years, per year+37.4%+15.2%
Worst drop · 1Y−30.2%−10.8%
Volatility · 1Y37.6%16.1%
4–2measures won
IXJ first
0.0%
holdings shared
Nov 4, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+35.3%
VIGVanguard
+16.4%
Jan 1Nov 4+35.3%+16.4%
+35.3%Year to date+16.4%
2.9%Yield1.4%
$121BAssets$109B
2–0SCHD wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+8.5%
JEPIJ.P. Morgan
+8.8%
Jan 1Nov 4+8.5%+8.8%
+8.5%Year to date+8.8%
12.2%Yield7.8%
$41.8BAssets$46.0B
1–1level
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+13.4%
SPYSPDR
+13.3%
Jan 1Nov 4+13.4%+13.3%
+13.4%Year to date+13.3%
1.0%Yield1.0%
$185BAssets$798B
1–0SPYM wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, IXJ

Today
0.0%most shared, BBC and IXJ
BBCIXJ
BBC—0.0%
IXJ0.0%—
End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$87most kept, IXJ
IXJ$125 − $38 = $87
BBC$150 − $65 = $85
KeptFee
End-of-day Nov 4, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com